Literature DB >> 1459210

Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells.

J Enenstein1, N S Waleh, R H Kramer.   

Abstract

Basic fibroblast growth factor (bFGF) and transforming growth factor-beta (TGF-beta) are known to alter the migratory and proliferative capacity of endothelial cells in vitro and to stimulate angiogenesis in vivo. One mechanism by which these cytokines induce their effects may be through the regulation of integrin adhesion receptor expression and activity. We examined the ability of these growth factors to modulate the expression of specific integrins in human microvascular endothelial cells (MEC). Immunoprecipitation of metabolically labeled MEC showed that bFGF upregulated the biosynthesis of alpha 2, alpha 5, beta 1, and beta 3. bFGF induced an increase in the levels of mRNA for alpha 2 and beta 1. TGF-beta increased synthesis of alpha 2, alpha 5, and beta 1. These results suggest that bFGF and TGF-beta selectively alter integrin profiles and influence interactions of MEC with the extracellular matrix during neovascularization. In particular, the upregulation of the collagen/laminin receptor, alpha 2 beta 1, by bFGF may provide activated endothelial cells with an enhanced capacity to migrate through both their underlying basement membrane and the interstitial matrix.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459210     DOI: 10.1016/0014-4827(92)90028-7

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis.

Authors:  P Nangia-Makker; Y Honjo; R Sarvis; S Akahani; V Hogan; K J Pienta; A Raz
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  The role of alphav integrins during angiogenesis.

Authors:  B P Eliceiri; D A Cheresh
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

3.  Growth factor expression in healing rabbit medial collateral and anterior cruciate ligaments.

Authors:  J Lee; F L Harwood; W H Akeson; D Amiel
Journal:  Iowa Orthop J       Date:  1998

Review 4.  Cellular adhesion molecules. Newly identified mediators of angiogenesis.

Authors:  P J Polverini
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Angiogenic potential of microvessel fragments established in three-dimensional collagen gels.

Authors:  J B Hoying; C A Boswell; S K Williams
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996 Jul-Aug       Impact factor: 2.416

6.  Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.

Authors:  D R Senger
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 7.  Role of the beta3 integrin subunit in human primary melanoma progression: multifunctional activities associated with alpha(v)beta3 integrin expression.

Authors:  R E Seftor
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

8.  Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma.

Authors:  Hee Seok Yang; Jaehoon Shin; Suk Ho Bhang; Jung Youn Shin; Jooyeon Park; Gun Il Im; Chang Sung Kim; Byung Soo Kim
Journal:  Exp Mol Med       Date:  2011-11-30       Impact factor: 8.718

9.  Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells.

Authors:  S Klein; F G Giancotti; M Presta; S M Albelda; C A Buck; D B Rifkin
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

10.  A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis.

Authors:  Oscar H P Ramos; Alexandre Kauskot; Márcia R Cominetti; Iga Bechyne; Carmen L Salla Pontes; Fabrice Chareyre; Jan Manent; Roger Vassy; Marco Giovannini; Chantal Legrand; Heloisa S Selistre-de-Araujo; Michel Crépin; Arnaud Bonnefoy
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.